TokenPost·
IGC Pharma Reports $0.32 Million in Third-Quarter Revenue
Net loss attributable to common stockholders widened to $2.046 million from $1.821 million, while basic and diluted loss per share was 2 cents.
More news
- TokenPostNational Energy Services Reunited Declares First $0.10 Quarterly Dividend
- TokenPostStrive's Bitcoin Holdings Rise to 43,153 BTC in Nov. 9 Tally
- TokenPostBlackRock's Bitcoin ETF Posts Seventh Straight Outflow of $213 Million
- TokenPostAbundia Revenue Rises 51% as Loss Narrows Amid Going-Concern Doubt
- CryptoPotatoPi Network’s PI Rockets 8% From ATL as Bitcoin Struggles to Hold $74K: Market Watch
- UnchainedCoinbase, Kalshi and Jump Trading Urge Judge to Keep Single-Stock Perps Trading